Edward Wu

NIH Rank #1129

Researcher identity and coverage

Current affiliation: Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity: Profile ID 79990259Search this ID in NIH RePORTER
ScienceDex PI coverage: FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

Linked Award Amount

$5.7M

Full award amounts, FY2025

Award Records

Records listing this PI

Award-Linked Rank

#1,129

By linked amount among FY2025 PIs

Earliest Year Loaded

2025

ScienceDex PI coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2025): $5.7M in linked award amounts across 8 award records · Award-linked rank #1129.

NIH award records listing Edward Wu as a PI. Multi-PI records show the full award amount for context.

1ZIATR000502-02ZIA
Development of D3 Antagonist for Substance Use Disorder
National Center for Advancing Translational Sciences
$1.3M
award amount
1ZIATR000503-02ZIA
Development of a Non-Paralyzing BoNT-based Biopharmaceutical for the Treatment of Neuropathic Pain
National Center for Advancing Translational Sciences
$1.3M
award amount
1ZIATR000501-02ZIA
Targeting Endosomal GPCR (eGPCR) Signaling Platforms for the Treatment of Chronic Pain
National Center for Advancing Translational Sciences
$1.3M
award amount
1ZIATR000439-04ZIA
Assay Development to Predict Toxicity of Antisense Oligonucleotide (ASO) Therapeutic Candidates for Rare Diseases
National Center for Advancing Translational Sciences
$617.7K
award amount
1ZIATR000535-01ZIA
Repositioning Basimglurant to Treat Hermansky-Pudlak Syndrome Pulmonary Fibrosis
National Center for Advancing Translational Sciences
$541.5K
award amount
1ZIATR000572-01ZIA
Development of an Antisense Oligonucleotide (ASO) Delivery Platform for Rare Diseases
National Center for Advancing Translational Sciences
$328K
award amount
1ZIATR000528-01ZIA
Development of Q203 (Telacebec) for the Treatment of Tuberculosis and Related Mycobacterial Infections
National Center for Advancing Translational Sciences
$243.6K
award amount
1ZIATR000441-04ZIA
Development of a Robust Bioprocess to Rapidly Produce Griffithsin, a Broad-Spectrum Therapeutic and Preventive Antiviral Candidate
National Center for Advancing Translational Sciences
$75K
award amount

Organizations that administered FY2025 awards listing Edward Wu as a PI.

Computed from the fiscal years currently available in ScienceDex.

Search NIH-funded principal investigators by topic, department, or activity.

Compare median NIH grant budgets across departments, mechanisms, and years.